Cardinal Health stock: Wall Street Zen upgrade pre-market
Published on 10/26/2026 at 08:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst action and current trading
- In its October 25, 2026 report, MarketBeat said Wall Street Zen upgraded Cardinal Health from buy to strong-buy.
- MarketBeat cited a consensus price target of USD 269.38 on October 25, 2026.
- Cardinal Health stock trades pre-market at EUR 222.70 at 8:02 a.m. CET at Lang & Schwarz on October 26, 2026.
Wall Street Zen upgraded Cardinal Health from buy to strong-buy in a report dated October 25, 2026, according to MarketBeat. Cardinal Health stock was at EUR 222.70 at Lang & Schwarz at 8:02 a.m. CET on October 26, 2026.
Analyst action from October 25
MarketBeat reported that Wall Street Zen changed its rating on Cardinal Health from buy to strong-buy. The report also cited 16 Buy ratings, three Holds and a consensus price target of USD 269.38 as of October 25, 2026. Those figures were attributed to MarketBeat's analyst coverage summary.
Ahead of the Xetra open
The pre-market indication is being monitored ahead of the Xetra session. The further course from the Xetra open at 9:00 a.m. CET is shown by the continuously updated real-time quote of Cardinal Health stock.
How Cardinal Health makes money
Cardinal Health supports the distribution and delivery of pharmaceuticals, medical products and related services for hospitals, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers, according to MarketBeat. Market context: Market report S&P 500.
